Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Fate Therapeutics Inc (NASDAQ:FATE)

1.59
Delayed Data
As of May 25
 -0.02 / -1.24%
Today’s Change
1.46
Today|||52-Week Range
8.37
-52.82%
Year-to-Date
No recent news for Fate Therapeutics Inc.

Today’s Trading

Previous close1.61
Today’s open1.62
Day’s range1.57 - 1.67
Volume115,355
Average volume (3 months)280,342
Market cap$46.5M
Dividend yield--
Data as of 05/25/2016

Growth & Valuation

Earnings growth (last year)+7.09%
Earnings growth (this year)-3.39%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales35.33
Price/Book1.22

Competitors

 Today’s
change
Today’s
% change
AEGRAegerion Pharmaceuti...-0.03-1.83%
AVDXAvant Diagnostics In...-0.03-7.89%
CANFCan Fite Biopharma L...-0.11-3.91%
CURNeuralstem Inc+0.01+4.01%
Data as of 9:30am ET, 05/25/2016

Financials

Next reporting dateAugust 3, 2016
EPS forecast (this quarter)-$0.31
Annual revenue (last year)$2.4M
Annual profit (last year)-$30.0M
Net profit margin-1,233.73%

Profile

Sector
Health Technology
Industry
Biotechnology
President &
Chief Executive Officer
J. Scott Wolchko
Chief Scientific Officer
Daniel D. Shoemaker
Corporate headquarters
San Diego, California

Forecasts

Partner Offers

Search for Jobs